Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven E Kahn

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Seminars in Cell & Developmental Biology|May 6, 2004
Engineering a new beta-cell: a critical venture requiring special attention to constantly changing physiological needsSteven E Kahn
Diabetes Care|December 25, 2012
Quantifying β-cells in health and disease: the past, the present, and the needSteven E Kahn
Diabetes|April 19, 2013
Incretin therapy and islet pathology: a time for cautionSteven E Kahn
JAMA|April 16, 2009
Glucose control in type 2 diabetes: still worthwhile and worth pursuingSteven E Kahn
Diabetes|April 21, 2025
The Normal 93: Linking the β-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et alDavid D'Alessio, Steven E Kahn
Diabetes Care|March 14, 2007
Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetesSteven E Kahn, Bernard Zinman
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Commentary: Of HOPEs and DREAMs: the quest to prevent type 2 diabetesVivian A Fonseca, Steven E Kahn
Diabetes|November 25, 2004
Suppression of Beta-cell secretion by somatostatin does not fully reverse the disproportionate proinsulinemia of type 2 diabetesMichael E Røder, Steven E Kahn
The Journal of Clinical Endocrinology and Metabolism|September 14, 2006
Review: The role of insulin resistance in nonalcoholic fatty liver diseaseKristina M Utzschneider, Steven E Kahn
Diabetologia|August 3, 2023
Daniel Porte Jr, 13 August 1931-13 May 2023Steven E Kahn, Michael W Schwartz
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Seminars in Cell & Developmental Biology|May 6, 2004
Engineering a new beta-cell: a critical venture requiring special attention to constantly changing physiological needsSteven E Kahn
Diabetes Care|December 25, 2012
Quantifying β-cells in health and disease: the past, the present, and the needSteven E Kahn
Diabetes|April 19, 2013
Incretin therapy and islet pathology: a time for cautionSteven E Kahn
JAMA|April 16, 2009
Glucose control in type 2 diabetes: still worthwhile and worth pursuingSteven E Kahn
Diabetes|April 21, 2025
The Normal 93: Linking the β-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et alDavid D'Alessio, Steven E Kahn
Diabetes Care|March 14, 2007
Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetesSteven E Kahn, Bernard Zinman
The Journal of Clinical Endocrinology and Metabolism|October 26, 2006
Commentary: Of HOPEs and DREAMs: the quest to prevent type 2 diabetesVivian A Fonseca, Steven E Kahn
Diabetes|November 25, 2004
Suppression of Beta-cell secretion by somatostatin does not fully reverse the disproportionate proinsulinemia of type 2 diabetesMichael E Røder, Steven E Kahn
The Journal of Clinical Endocrinology and Metabolism|September 14, 2006
Review: The role of insulin resistance in nonalcoholic fatty liver diseaseKristina M Utzschneider, Steven E Kahn
Diabetologia|August 3, 2023
Daniel Porte Jr, 13 August 1931-13 May 2023Steven E Kahn, Michael W Schwartz
Pageof 35